| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | 
|---|---|---|---|---|---|
Gross Sales  | 2,387.03  | 2,528.58  | 2,716.05  | 2,488.65  | 2,154.78  | 
Excise Duty  | 0  | 0  | 0  | 0  | 0  | 
Net Sales  | 2,387.03  | 2,528.58  | 2,716.05  | 2,488.65  | 2,154.78  | 
Other Operating Income  | 0  | 0  | 0  | 0  | 0  | 
Other Income  | 16.36  | 4.03  | 2.19  | 11.32  | 4.74  | 
Total Income  | 2,403.39  | 2,532.61  | 2,718.24  | 2,499.97  | 2,159.52  | 
Total Expenditure  | 2,099.96  | 2,212.12  | 2,410.45  | 2,159.21  | 1,717.67  | 
PBIDT  | 303.43  | 320.49  | 307.79  | 340.76  | 441.85  | 
Interest  | 35.87  | 33.52  | 33.29  | 20.75  | 22.96  | 
PBDT  | 267.56  | 286.97  | 274.5  | 320.01  | 418.89  | 
Depreciation  | 55.78  | 51.45  | 50.32  | 50.05  | 49.88  | 
Minority Interest Before NP  | 0  | 0  | 0  | 0  | 0  | 
Tax  | 41.18  | 59.56  | 58.86  | 69.74  | 93.08  | 
Deferred Tax  | 2.5  | 4.37  | -1.04  | -4.78  | -4.47  | 
Reported Profit After Tax  | 168.1  | 171.59  | 166.36  | 205  | 280.4  | 
Minority Interest After NP  | -0.06  | 0.17  | 0.05  | -0.04  | -0.01  | 
Net Profit after Minority Interest  | 168.16  | 171.42  | 166.31  | 205.04  | 280.41  | 
Extra-ordinary Items  | 0  | 0  | 0  | 0  | 0.16  | 
Adjusted Profit After Extra-ordinary item  | 168.16  | 171.42  | 166.31  | 205.04  | 280.25  | 
EPS (Unit Curr.)  | 18.35  | 18.56  | 17.97  | 22.12  | 30.09  | 
Book Value (Unit Curr.)  | 0  | 0  | 0  | 0  | 0  | 
Dividend (%)  | 10  | 10  | 10  | 10  | 25  | 
Equity  | 91.27  | 91.94  | 92.6  | 92.6  | 93.2  | 
Public Shareholding (Number)  | 0  | 0  | 0  | 0  | 0  | 
Public Shareholding (%)  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - No. of Shares  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - % in Total Promoters Holding  | 0  | 0  | 0  | 0  | 0  | 
Pledged/Encumbered - % in Total Equity  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - No. of Shares  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - % in Total Promoters Holding  | 0  | 0  | 0  | 0  | 0  | 
Non Encumbered - % in Total Equity  | 0  | 0  | 0  | 0  | 0  | 
PBIDTM(%)  | 12.71  | 12.67  | 11.33  | 13.69  | 20.5  | 
PBDTM(%)  | 11.2  | 11.34  | 10.1  | 12.85  | 19.44  | 
PATM(%)  | 7.04  | 6.78  | 6.12  | 8.23  | 13.01  | 
The consolidated net profit of the company increased 1.1% YoY at ₹37.1 crore from ₹36.7 crore that was reported for the same quarter last year.
Aarti Drugs shares has witnessed a 8% dip in the last one year, and 10% dip in the last six months.
Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Bank of Baroda, HDFC Bank, etc.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.